The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month. But let's face facts -- ...

Global private equity and venture capital investments in pharmaceutical companies lag 2024 figures, and regulatory headwinds ...

Positioned to Unlock M&A Value through U.S. Manufacturing Amidst Geopolitical Complexities and Specialty Portfolio ...

Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data ...

One of Mission’s largest employers announced mass layoffs in the company, citing financial concerns and a “challenging ...

AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...

Complete Zealand Pharma A/S ADR stock information by Barron's. View real-time ZLDPY stock price and news, along with industry-best analysis.

Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's ...

Drug prices in the United States are astronomical and climbing. Many analysts blame mergers and acquisitions among ...

Earlier, the company had announced its intent to acquire agricultural land in the strategically vital region of Kutch, ...

Notice of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing ...

Regeneron Pharmaceuticals has promised to comply with 23andMe's existing privacy polices while also using data to fuel drug ...